CAMP (Camp4 Therapeutics) Piotroski F-Score

View and export this data going back to 2024. Start your Free Trial

What is Camp4 Therapeutics Piotroski F-Score?

Camp4 Therapeutics does not have enough data to calculate Piotroski F-Score.

Camp4 Therapeutics Piotroski F-Score Historical Data

The historical data trend for Camp4 Therapeutics's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camp4 Therapeutics Piotroski F-Score Chart

Camp4 Therapeutics Annual Data

Trend

Dec22

Dec23

Piotroski F-Score

Camp4 Therapeutics Quarterly Data
	Dec22	Jun23	Dec23	Jun24
Piotroski F-Score	-	-	-	-

Camp4 Therapeutics (NAS:CAMP) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.

Camp4 Therapeutics Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Camp4 Therapeutics's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Camp4 Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camp4 Therapeutics Corp (NAS:CAMP) » Definitions » Piotroski F-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA, USA

Website

https://www.camp4tx.com

Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.